A genetically edited form of a herpes simplex virus has outperformed a leading vaccine candidate in a new study. When challenged with a virulent strain of the sexually transmitted HSV-2, vaccinated guinea pigs displayed fewer genital lesions, less viral replication and less of the viral shedding that most readily spreads infection.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023